Cronos Group (CRON) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cronos Group (CRON) has outperformed Regencell Bioscience (RGC) over the past year, gaining 20.1% versus a loss of 60.7%. Over five years, RGC leads with a +1455.6% price change compared with -41.2% for CRON.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | RGC |
|---|---|---|
| Share price | $3.22 | $7.63 |
| Market cap | $1.19B | — |
| 1-day change | -0.62% | +7.31% |
| YTD return | +22.43% | -63.67% |
| 1-year return | +20.15% | -60.67% |
| 5-year return | -41.24% | +1455.56% |
| P/E ratio (TTM) | 16.95 | — |
| EPS (TTM) | $0.19 | $-0.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $3.61 | $69.00 |
| 52-week low | $2.28 | $4.51 |
| Distance from 52-week high | -10.75% | -88.94% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | -23.29% | — |
| Average volume | 1.13M | 199.19K |
| Shares outstanding | 368.41M | — |
| Employees | 610 | 10 |
| Sector | Healthcare | Health Care |
| Industry | Drug Manufacturers - Specialty & Generic | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CRON has outperformed RGC by 80.8 percentage points over the past year.
- The two companies sit in different sectors: Cronos Group in Healthcare and Regencell Bioscience in Health Care.
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Healthcare · Drug Manufacturers - Specialty & Generic · 610 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
CRON vs RGC FAQ
Which stock has performed better over the past year, CRON or RGC?
CRON returned +20.15% over the past 12 months, compared with -60.67% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Cronos Group and Regencell Bioscience in the same industry?
No. Cronos Group is in the Healthcare sector, while Regencell Bioscience is in Health Care.